CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands |
Total |
Common stock |
Additional paid-in capital |
Retained earnings |
Accumulated other comprehensive income (loss) |
Treasury stock |
Noncontrolling interest in consolidated subsidiaries |
|||
---|---|---|---|---|---|---|---|---|---|---|
Increase (Decrease) in Shareholders' Equity | ||||||||||
Impact of ASC 842 adoption | $ 1,175,738 | $ 27,900 | $ 0 | $ 2,067,811 | $ (303,185) | $ (692,549) | $ 75,761 | |||
Beginning balance at Dec. 29, 2018 | 1,175,738 | 27,900 | 0 | 2,067,811 | (303,185) | (692,549) | 75,761 | |||
Increase (Decrease) in Shareholders' Equity | ||||||||||
Impact of ASC 842 adoption | 1,165,174 | 27,900 | 0 | 2,067,811 | (303,185) | (692,549) | 75,761 | |||
Net earnings | 77,746 | 75,823 | 1,923 | |||||||
Other comprehensive income (loss) | 282 | 113 | 169 | |||||||
Cash dividends declared | (16,339) | (16,339) | ||||||||
Dividends to noncontrolling interests | (4,459) | (4,459) | ||||||||
Purchase of noncontrolling interest | (27,845) | 277 | (28,122) | |||||||
Purchase of treasury shares, shares acquired | (38,350) | (38,350) | ||||||||
Stock plan exercises, shares acquired | (827) | (827) | ||||||||
Stock options exercised | 1,744 | (5,242) | 5,345 | 1,641 | ||||||
Stock option expense | 1,456 | 1,456 | ||||||||
Stock awards | 4,914 | 3,509 | 1,405 | |||||||
Ending balance at Jun. 29, 2019 | 1,165,174 | 27,900 | 0 | 2,123,754 | [1] | (303,072) | (728,680) | 45,272 | ||
Increase (Decrease) in Shareholders' Equity | ||||||||||
Impact of ASC 842 adoption | 1,171,053 | 27,900 | 0 | 2,089,276 | [1] | (298,740) | (700,333) | 52,950 | ||
Beginning balance at Mar. 30, 2019 | 1,171,053 | 27,900 | 0 | 2,089,276 | [1] | (298,740) | (700,333) | 52,950 | ||
Increase (Decrease) in Shareholders' Equity | ||||||||||
Impact of ASC 842 adoption | 1,165,174 | 27,900 | 0 | 2,123,754 | [1] | (303,072) | (728,680) | 45,272 | ||
Net earnings | 40,668 | 39,719 | 949 | |||||||
Other comprehensive income (loss) | (4,298) | (4,332) | 34 | |||||||
Cash dividends declared | (8,126) | (8,126) | ||||||||
Dividends to noncontrolling interests | (3,621) | (3,621) | ||||||||
Purchase of noncontrolling interest | (4,763) | 277 | (5,040) | |||||||
Purchase of treasury shares, shares acquired | (28,929) | (28,929) | ||||||||
Stock plan exercises, shares acquired | (80) | (80) | ||||||||
Stock options exercised | 570 | (2,575) | 2,885 | 260 | ||||||
Stock option expense | 728 | 728 | ||||||||
Stock awards | 1,972 | 1,570 | 402 | |||||||
Ending balance at Jun. 29, 2019 | 1,165,174 | 27,900 | 0 | 2,123,754 | [1] | (303,072) | (728,680) | 45,272 | ||
Increase (Decrease) in Shareholders' Equity | ||||||||||
Impact of ASC 842 adoption | 1,165,174 | 27,900 | 0 | 2,123,754 | [1] | (303,072) | (728,680) | 45,272 | ||
Impact of ASC 842 adoption | 1,189,745 | 27,900 | 0 | 2,173,802 | (313,422) | (743,942) | 45,407 | |||
Beginning balance at Dec. 28, 2019 | 1,189,745 | 27,900 | 0 | 2,173,802 | (313,422) | (743,942) | 45,407 | |||
Increase (Decrease) in Shareholders' Equity | ||||||||||
Impact of ASC 842 adoption | 1,152,702 | 27,900 | 0 | 2,194,916 | (332,486) | (763,495) | 25,867 | |||
Net earnings | 65,475 | 65,536 | (61) | |||||||
Other comprehensive income (loss) | (18,576) | (19,064) | 488 | |||||||
Cash dividends declared | (19,223) | (19,223) | ||||||||
Dividends to noncontrolling interests | (5,642) | (5,642) | ||||||||
Purchase of noncontrolling interest | (50,111) | 0 | (30,661) | (19,450) | ||||||
Addition of noncontrolling interest | 5,125 | 5,125 | ||||||||
Purchase of treasury shares, shares acquired | (20,481) | (20,481) | ||||||||
Stock plan exercises, shares acquired | (5) | (5) | ||||||||
Stock options exercised | 724 | (5,217) | 5,462 | 479 | ||||||
Stock option expense | 1,223 | 1,223 | ||||||||
Stock awards | 4,448 | 3,994 | 454 | |||||||
Ending balance at Jun. 27, 2020 | 1,152,702 | 27,900 | 0 | 2,194,916 | (332,486) | (763,495) | 25,867 | |||
Increase (Decrease) in Shareholders' Equity | ||||||||||
Impact of ASC 842 adoption | 1,110,130 | 27,900 | 0 | 2,171,329 | [1] | (347,868) | (763,950) | 22,719 | ||
Beginning balance at Mar. 28, 2020 | 1,110,130 | 27,900 | 0 | 2,171,329 | [1] | (347,868) | (763,950) | 22,719 | ||
Increase (Decrease) in Shareholders' Equity | ||||||||||
Impact of ASC 842 adoption | 1,152,702 | 27,900 | 0 | 2,194,916 | (332,486) | (763,495) | 25,867 | |||
Net earnings | 22,754 | 22,607 | 147 | |||||||
Other comprehensive income (loss) | 15,365 | 15,382 | (17) | |||||||
Cash dividends declared | (9,598) | (9,598) | ||||||||
Dividends to noncontrolling interests | (300) | (300) | ||||||||
Purchase of noncontrolling interest | 7,818 | 0 | 8,025 | (207) | ||||||
Addition of noncontrolling interest | 3,525 | 3,525 | ||||||||
Stock plan exercises, shares acquired | (2) | (2) | ||||||||
Stock options exercised | 664 | (2,206) | 2,553 | 317 | ||||||
Stock option expense | 612 | 612 | ||||||||
Stock awards | 1,734 | 1,594 | 140 | |||||||
Ending balance at Jun. 27, 2020 | 1,152,702 | 27,900 | 0 | 2,194,916 | (332,486) | (763,495) | 25,867 | |||
Increase (Decrease) in Shareholders' Equity | ||||||||||
Impact of ASC 842 adoption | $ 1,152,702 | $ 27,900 | $ 0 | $ 2,194,916 | $ (332,486) | $ (763,495) | $ 25,867 | |||
|